By: Benzinga
March 14, 2013 at 16:01 PM EDT
Cadence Pharmaceuticals Appoints Stephen Newman, M.D., to its Board of Directors
Cadence Pharmaceuticals (NASDAQ: CADX ), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, announced today the appointment of Stephen L. Newman, M.D., to the company's board of directors. "We are very pleased to welcome Dr. Newman to our board
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here